Keywords

• NCX-116
• UNII-I6393O0922
• Latanoprostene bunod

Quick Details

• ProName: Latanoprostene bunod
• CasNo: 860005-21-6
• Molecular Formula: C27H41NO8
• Appearance: White powder
• Application: Latanoprostene bunod (NCX116; LBN) is ...
• DeliveryTime: 3-7
• PackAge: Bucket/bag
• Port: Tianjin Newport/Qingdao Port
• ProductionCapacity: 1000 Metric Ton/Day
• Purity: ≥99%
• Storage: Pure form-20°C3 years 4°C2 years In s...
• Transportation: By air/sea
• LimitNum: 1 Gram

Superiority

Hebei Tecxiang Chemical Co., Ltd. is an enterprise specializing in the research and development, production and trade of pharmaceutical intermediates, apis and chemical raw materials and formula technology. Our company has extensive experience in the synthesis of organic molecules ranging from milligrams to hundreds of kilograms, and specializes in customized synthesis, synthesis research, manufacturing and production services for pharmaceutical and research and development companies to produce pharmaceutical intermediates and fine chemicals. Our company maintains close cooperation with well-known pharmaceutical enterprises at home and abroad, and has the right to import and export. Our research and development products are mainly sold to well-known pharmaceutical companies at home and abroad, and won the praise of customers.

The company covers an area of 33,616 square meters. At present, the company's total construction area of 24,392 square meters, fixed assets of 60.78 million yuan, the annual actual production of ethylene oxide derivatives 60,000 tons, including medical intermediates and excipients 10,000 tons, green surfactants 50,000 tons. The annual sales revenue exceeds 300 million yuan. There are 76 employees, including 24 professional and technical personnel. It has been identified as a "high-tech enterprise" by the Torch Center of the Ministry of Science and Technology, a "small and medium-sized technology-based enterprise" by the Department of Science and Technology of Hebei Province, and an "enterprise above scale" by the Ministry of Finance. Has obtained 15 practical technology and soft patent technology, and enjoy 6 years of national exclusive chemical generic drug production policy protection.

Details

Describe Latanoprostene bunod (NCX116; LBN) is a nitric oxide (NO) donor prostaglandin F2a analogue that can be used for topical ophthalmic treatment to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension (OHT).
Related category
Signaling path >> Other >> Other
Field of Study >> Neurological diseases
Reference literature
[1]. Cavet ME, et al. The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies. J Ocul Pharmacol Ther. 2018 Jan/Feb; 34 (1-2) : 52-60.
Physical and chemical properties of Latanoprostene bunod
Molecular formula C27H41NO8
Molecular weight 507.62
Accurate mass 507.28300
PSA 142.04000
LogP 4.28970
Latanoprostene bunod
NCX-116
UNII-I6393O0922
Latanoprostene BUNOD